07:00 a.m. – 08:00 a.m. – Registration, Breakfast and Exhibits
07:55 a.m. – 08:00 a.m. Welcoming Remarks and Introduction of Keynote Speaker Shahla Masood, MD
08:00 a.m. – 09:00 a.m. Keynote Lecture – Changing Landscape in the Regional Nodal Management of Breast Cancer Bruce Haffty, MD
Session I: The Status of Breast Cancer Across the Globe Moderator: Pat Whitworth, MD
09:00 a.m. – 09:30 a.m. Addressing the Continuous Dilemma of Breast Cancer Disparities Among Medically Underserved Population. A Call to Action Shahla Masood, MD
09:30 a.m. – 10:00 a.m. Global Disparities in Genetic Cancer Risk Assessment: Access, Biology or Both Pat Whitworth, MD
10:00 a.m. – 10:30 a.m. BREAK and EXHIBITS
10:30 a.m. – 11:00 a.m. Breast Cancer Screening Among the Elderly Dejana Braithwaite, PhD, MSc
11:00 a.m. – 11:30 a.m. BESPOKE ctDNA Monitoring for Breast Cancer Treatment and Surveillance Pat Whitworth, MD
11:30 a.m. – 12:00 p.m. Panel Discussion Dejana Braithwaite, PhD, MSc; Bruce Haffty, MD; Shahla Masood, MD; and Pat Whitworth, MD
12:00 p.m. – 1:00 p.m. LUNCH AND EXHIBITS
Session II: Breast Cancer Screening and Diagnoses Moderator: Freya Schnabel, MD
01:00 p.m. – 01:30 p.m. An Update on Breast Cancer Genetics Banu Arun, MD
01:30 p.m. – 02:00 p.m. Management of High Risk Breast Cancer Patients Freya Schnabel, MD
02:00 p.m. – 02:30 p.m. BREAK and EXHIBITS
02:30 p.m. – 03:15 p.m. Abbreviated Breast MRI for Screening Women with Dense Breast Christopher E Comstock, MD
03:15 p.m. – 03:45 p.m. Current Status of Breast Ultrasound Screening in Women with Dense Breast Reni Butler, MD
03:45 p.m. – 04:30 p.m. Contrast Enhanced Spectral Mammography: Technique and Applications Christopher E. Comstock, MD
04:30 p.m. – 05:00 p.m. Panel Discussion: Banu Arun, MD; Reni Butler, MD; Christopher E. Comstock, MD; and Freya Schnabel, MD
Saturday, Feb. 11, 2023
07:00 a.m. – 08:00 a.m. – Registration, Breakfast and Exhibits
Session III: New Concepts in Surgical Management Moderator: Terry Mamounas, MD
08:00 a.m. – 08:30 a.m. Is it Time to Abandon the Term of Low Grade Ductal Carcinoma in situ and Replace it with “Borderline Breast Lesions” in Breast Core Needle Biopsy? Shahla Masood, MD
08:30 a.m. – 09:00 a.m. Update on Surgical Management of Ductal Carcinoma in situ Shelley Hwang, MD, MPH
09:00 a.m. – 09:30 a.m. Radiation Therapy for Ductal Carcinoma in situ: Is it Necessary for Low Grade Ductal Carcinoma in situ? Bruce Haffty, MD
09:30 a.m. – 10:00 a.m. BREAK AND EXHIBITS
10:00 a.m. – 10:30 a.m. The Dilemma of Positive Margins Shelley Hwang, MD, MPH
10:30 a.m. – 11:00 a.m. Surgical Techniques to Reduce Morbidity from Axillary Surgery Terry Mamounas, MD
11:00 a.m. – 11:30 a.m. Oncoplastic Breast Conservation for Just About all Patients Melvin J. Silverstein, MD
11:30 a.m. – 12:00 p.m. Panel Discussion: Bruce Haffty, MD; Shelley Hwang, MD, MPH; Terry Mamounas, MD; Shahla Masood, MD and Melvin J. Silverstein, MD
12:00 p.m. – 1:00 p.m. LUNCH AND EXHIBITS
Session IV: Advances in Breast Cancer Therapy Moderator: Elizabeth A. Mittendorf, MD, PhD
01:00 p.m. – 01:30 p.m. Beyond Breast Reconstruction: Breast Regeneration John D. Murray, MD
01:30 p.m. – 02:00 p.m. Axillary Management after Neoadjuvant Chemotherapy Terry Mamounas, MD
02:00 p.m. – 02:30 p.m. MBC: Role of Immunotherapy and Updates on CDK4/6i Claudine Isaacs, MD
02:30 p.m. – 03:00 p.m. Neoadjuvant Immunotherapy Elizabeth A. Mittendorf, MD, PhD
03:00 p.m. – 03:30 p.m.BREAK and EXHIBITS
03:30 p.m. – 04:00 p.m. ER+ Early Stage Breast Cancer: Who Needs Chemotherapy and Role of CDK4/6i Claudine Isaacs, MD
04:00 p.m. – 04:30 p.m. Antibody-Drug Conjugates for Breast Cancer: What is New? Banu Arun, MD
04:30 p.m. – 05:00 p.m. Panel Discussion: Banu Arun, MD; Claudine Isaacs, MD; Terry Mamounas, MD; Elizabeth A. Mittendorf, MD, PhD; and John D. Murray, MD
Sunday, Feb. 12, 2023
7:00 a.m. – 8:00 a.m. – Registration, Breakfast and Exhibits
Session V: Contemporary Issues in Breast Cancer Moderator: Shahla Masood, MD
08:00 a.m. – 08:30 a.m. An Overview of Breast Cancer Biomarker Testing Gary Tozbikian, MD
